$DLB

Dolby Laboratories Reports Third Quarter 2026 Financial Results

Copyright 2026 PR Newswire. All Rights Reserved 2026-07-30 SAN FRANCISCO, July 30, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the third quarter of fiscal 2026. "We continue to execute against our full-year objectives, and we are building momentum across several of our key growth areas," said Kevin Yeaman, President and CEO, Dolby Laboratories.

Original reporting
Published Jul 30, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 30, 2026, 9:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$DLB
Neutral
medium confidence
Mentioned
$DLB
Relevance
9/10
alphai data visualization · based on itnewsonline.com
Decision brief

The 30-second read

$DLBNeutralHigh
01

Why it matters

Traders can reprice DLB based on the new Q4 revenue, licensing revenue, margin, and EPS ranges, and also factor in capital return (dividend plus $350M repurchase authorization).

02

Market read

A full earnings and guidance package with quantified ranges plus capital return updates makes this a direct catalyst for DLB positioning.

03

What to watch

Royalty-based revenue uncertainty and the mix of licensing versus other revenue streams may matter more than headline revenue growth, but the article does not break out segment drivers.

Relevance 9/10Novelty 9/10Timing: post-market release today, with Q4 and full-year guidance issued in the same statement

Background

Dolby’s Q3 FY2026 release includes GAAP and non-GAAP results, a dividend, an expanded repurchase authorization, and detailed Q4 and FY2026 guidance ranges.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Dolby reported Q3 FY2026 results and guided Q4 revenue $362M to $392M, plus EPS $0.78 to $0.93 GAAP.

Expected impact

Likely near-term volatility around the Q4 revenue and EPS ranges, with direction depending on how the market interprets licensing revenue and margin assumptions.

Evidence & confidence

This is a primary earnings and guidance disclosure with quantified ranges, but the article provides no consensus comparison or surprise magnitude versus expectations.

Market effects

Signals demand and royalty/licensing momentum for audio-video technology licensing, which can influence sentiment across media-tech and content distribution infrastructure.

Limited direct regional read-through; mostly US-listed earnings impact for DLB.

Global content partnerships and device ecosystem adoption (TVs, AR glasses, cameras, automotive) reinforce international royalty exposure.

Counterpoint

Despite guidance, the company flags reduced visibility from macro, trade restrictions, and geopolitical risks, which can cap multiple expansion.

Key entities

  • Dolby Laboratories, Inc.

    NYSE-listed audio-video technology licensor reporting Q3 FY2026 results and issuing Q4 and FY2026 guidance.

  • Kevin Yeaman

    CEO quoted on execution and growth areas including Video Distribution Program and Dolby OptiView.

  • Meta Platforms, Inc.

    Named as a licensee joining Dolby’s VDP program (content distribution partnership detail).

Related articles

$DLBMed

Dolby Laboratories, Inc. Q3 2026 Earnings Call Summary

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

$DLBMed

Why Dolby Labs Stock Popped Today

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

$DLBMedAI 8/10

Dolby (DLB) Q3 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

$DLBMed

Dolby Laboratories (NYSE:DLB) Misses Q2 CY2026 Sales Expectations

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?

$DLBHigh

Dolby Laboratories, Inc. (DLB): Results of Operations and Financial Condition

Dolby Laboratories, Inc. (DLB) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d165402dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Dolby Laboratories Reports Third Quarter 2026 Financial Results SAN FRANCISCO, July 30, 2026 — Dolby Laboratories, Inc. (NYSE:DLB) today announced the company’s financial results for the third quarter of fiscal 2026. “We co

$DTMedAI 8/10

Dynatrace Springs on Q1 Figures

Dynatrace (NYSE: DT) reported Q1 FY2027 results for the quarter ended June 30, 2026. Total ARR was $2,136 million, up 17%. Total revenue rose to $555 million, up 16%. Subscription revenue was $530 million. GAAP operating income was $71 million and non-GAAP $162 million. CEO Rick McConnell cited 41% organic net new ARR growth and accelerating TTM growth.